Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has provided an announcement.
Jiangsu Recbio Technology Co., Ltd. held its Annual General Meeting on June 20, 2025, where all proposed resolutions were passed. These resolutions included approvals of financial reports, work reports, and the appointment of a board observer, as well as amendments to the Articles of Association. The successful passage of these resolutions indicates strong shareholder support and positions the company for continued strategic development and operational enhancements.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in China, operating in the biotechnology industry. The company focuses on the development and commercialization of innovative vaccines and related products, aiming to address global health challenges.
Average Trading Volume: 66,775
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.07B
See more data about 2179 stock on TipRanks’ Stock Analysis page.